Met Life Investment Management, LLC Rigel Pharmaceuticals Inc Transaction History

Met Life Investment Management, LLC

$14.7 Billion
Q1 2024

A detailed history of Met Life Investment Management, LLC transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 72,418 shares of RIGL stock, worth $609,759. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,418

Holding current value

$609,759

% of portfolio

0.0%

67 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.12 - $1.57 $81,108 - $113,696	72,418 New	72,418 $107,000
Q2 2023 Apr 29, 2024	BUY	$1.12 - $1.82 $103,850 - $168,757	92,724 New	92,724 $119,000
Q1 2023 May 09, 2024	BUY	$1.25 - $2.0 $115,905 - $185,448	92,724 New	92,724 $122 Million
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $34,898 - $55,838	27,919 Added 43.08%	92,724 $122,000
Q4 2022 May 10, 2024	SELL	$0.67 - $1.5 $20,474 - $45,838	-30,559 Reduced 32.04%	64,805 $97,000

Q4 2022 Jun 14, 2023	SELL	$0.67 - $1.5 $18,705 - $41,878	-27,919 Reduced 30.11%	64,805 $97,000
Q4 2022 Mar 22, 2023	SELL	$0.67 - $1.5 $20,474 - $45,838	-30,559 Reduced 32.04%	64,805 $97,000
Q4 2022 Feb 15, 2023	SELL	$0.67 - $1.5 $20,474 - $45,838	-30,559 Reduced 32.04%	64,805 $97,000
Q3 2022 May 10, 2024	BUY	$1.1 - $1.72 $96,411 - $150,752	87,647 Added 1135.77%	95,364 $104,000
Q3 2022 Jun 14, 2023	BUY	$1.1 - $1.72 $2,904 - $4,540	2,640 Added 2.85%	95,364 $104,000
Q3 2022 Mar 22, 2023	BUY	$1.1 - $1.72 $96,411 - $150,752	87,647 Added 1135.77%	95,364 $104,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $1.72 $96,411 - $150,752	87,647 Added 1135.77%	95,364 $113,000
Q2 2022 May 10, 2024	SELL	$0.67 - $3.19 $52,255 - $248,797	-77,993 Reduced 91.0%	7,717 $8,000
Q2 2022 Jun 20, 2023	SELL	$0.67 - $3.19 $56,954 - $271,172	-85,007 Reduced 91.68%	7,717 $8,000
Q2 2022 Mar 22, 2023	SELL	$0.67 - $3.19 $52,255 - $248,797	-77,993 Reduced 91.0%	7,717 $8,000
Q2 2022 Aug 11, 2022	SELL	$0.67 - $3.19 $52,255 - $248,797	-77,993 Reduced 91.0%	7,717 $9,000
Q1 2022 May 10, 2024	BUY	$2.22 - $3.45 $190,276 - $295,699	85,710 New	85,710 $256,000
Q1 2022 Jun 20, 2023	SELL	$2.22 - $3.45 $15,571 - $24,198	-7,014 Reduced 7.56%	85,710 $256,000
Q1 2022 Mar 22, 2023	BUY	$2.22 - $3.45 $124,606 - $193,645	56,129 Added 189.75%	85,710 $256,000
Q1 2022 May 12, 2022	BUY	$2.22 - $3.45 $124,606 - $193,645	56,129 Added 189.75%	85,710 $256,000
Q4 2021 May 17, 2024	SELL	$2.36 - $3.57 $75,484 - $114,186	-31,985 Reduced 51.95%	29,581 $78,000
Q4 2021 Jun 21, 2023	SELL	$2.36 - $3.57 $149,017 - $225,420	-63,143 Reduced 68.1%	29,581 $78,000
Q4 2021 Mar 22, 2023	SELL	$2.36 - $3.57 $75,484 - $114,186	-31,985 Reduced 51.95%	29,581 $78,000
Q4 2021 Feb 15, 2022	SELL	$2.36 - $3.57 $75,484 - $114,186	-31,985 Reduced 51.95%	29,581 $78,000
Q3 2021 May 17, 2024	BUY	$3.5 - $4.5 $69,517 - $89,379	19,862 Added 47.63%	61,566 $223,000
Q3 2021 Jun 21, 2023	SELL	$3.5 - $4.5 $109,053 - $140,211	-31,158 Reduced 33.6%	61,566 $223,000
Q3 2021 Mar 22, 2023	BUY	$3.5 - $4.5 $69,517 - $89,379	19,862 Added 47.63%	61,566 $223,000
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $69,517 - $89,379	19,862 Added 47.63%	61,566 $223,000
Q2 2021 May 17, 2024	SELL	$3.09 - $4.54 $85,351 - $125,403	-27,622 Reduced 39.84%	41,704 $180,000
Q2 2021 Jun 21, 2023	SELL	$3.09 - $4.54 $157,651 - $231,630	-51,020 Reduced 55.02%	41,704 $180,000
Q2 2021 Mar 22, 2023	SELL	$3.09 - $4.54 $85,351 - $125,403	-27,622 Reduced 39.84%	41,704 $180,000
Q2 2021 Aug 16, 2021	SELL	$3.09 - $4.54 $85,351 - $125,403	-27,622 Reduced 39.84%	41,704 $181,000
Q1 2021 May 17, 2024	SELL	$3.35 - $4.93 $10,358 - $15,243	-3,092 Reduced 4.27%	69,326 $237,000
Q1 2021 Jun 26, 2023	SELL	$3.35 - $4.93 $78,383 - $115,352	-23,398 Reduced 25.23%	69,326 $237 Million
Q1 2021 Mar 22, 2023	BUY	$3.35 - $4.93 $72,175 - $106,216	21,545 Added 45.09%	69,326 $237,000
Q1 2021 May 14, 2021	BUY	$3.35 - $4.93 $72,175 - $106,216	21,545 Added 45.09%	69,326 $237,000
Q4 2020 May 24, 2024	BUY	$2.35 - $3.74 $1,630 - $2,595	694 Added 1.47%	47,781 $167,000
Q4 2020 Jun 22, 2023	SELL	$2.35 - $3.74 $105,616 - $168,086	-44,943 Reduced 48.47%	47,781 $167,000
Q4 2020 Mar 22, 2023	BUY	$2.35 - $3.74 $1,630 - $2,595	694 Added 1.47%	47,781 $167,000
Q4 2020 Feb 16, 2021	BUY	$2.35 - $3.74 $1,630 - $2,595	694 Added 1.47%	47,781 $167,000
Q3 2020 May 24, 2024	SELL	$1.78 - $4.13 $60,345 - $140,015	-33,902 Reduced 41.86%	47,087 $113 Million
Q3 2020 Jun 26, 2023	SELL	$1.78 - $4.13 $81,233 - $188,480	-45,637 Reduced 49.22%	47,087 $113,000
Q3 2020 Mar 22, 2023	SELL	$1.78 - $4.13 $60,345 - $140,015	-33,902 Reduced 41.86%	47,087 $113,000
Q3 2020 Nov 13, 2020	SELL	$1.78 - $4.13 $60,345 - $140,015	-33,902 Reduced 41.86%	47,087 $113,000
Q2 2020 May 24, 2024	BUY	$1.41 - $2.05 $12,085 - $17,570	8,571 Added 11.84%	80,989 $148 Million
Q2 2020 Jun 26, 2023	SELL	$1.41 - $2.05 $16,546 - $24,056	-11,735 Reduced 12.66%	80,989 $148,000
Q2 2020 Mar 22, 2023	BUY	$1.41 - $2.05 $58,151 - $84,546	41,242 Added 103.76%	80,989 $148,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $58,151 - $84,546	41,242 Added 103.76%	80,989 $148,000
Q1 2020 Jul 12, 2023	SELL	$1.27 - $3.0 $67,280 - $158,931	-52,977 Reduced 57.13%	39,747 $62,000
Q1 2020 Mar 22, 2023	SELL	$1.27 - $3.0 $55,361 - $130,776	-43,592 Reduced 52.31%	39,747 $62,000
Q1 2020 May 15, 2020	SELL	$1.27 - $3.0 $55,361 - $130,776	-43,592 Reduced 52.31%	39,747 $62,000
Q4 2019 Jul 12, 2023	SELL	$1.6 - $2.43 $15,016 - $22,805	-9,385 Reduced 10.12%	83,339 $178,000
Q4 2019 Mar 22, 2023	BUY	$1.6 - $2.43 $111,161 - $168,826	69,476 Added 501.16%	83,339 $178,000
Q4 2019 Feb 14, 2020	BUY	$1.6 - $2.43 $111,161 - $168,826	69,476 Added 501.16%	83,339 $178,000
Q3 2019 Jul 12, 2023	SELL	$1.63 - $2.62 $128,543 - $206,615	-78,861 Reduced 85.05%	13,863 $25,000
Q3 2019 Mar 22, 2023	SELL	$1.63 - $2.62 $88,484 - $142,226	-54,285 Reduced 79.66%	13,863 $25,000
Q3 2019 Nov 14, 2019	SELL	$1.63 - $2.62 $88,484 - $142,226	-54,285 Reduced 79.66%	13,863 $26,000
Q2 2019 Jul 12, 2023	BUY	$2.02 - $2.61 $29,263 - $37,811	14,487 Added 15.62%	107,211 $279,000
Q1 2019 Jul 13, 2023	SELL	$2.0 - $2.65 $49,152 - $65,126	-24,576 Reduced 26.5%	68,148 $175,000
Q4 2018 Jul 13, 2023	SELL	$2.08 - $3.36 $51,118 - $82,575	-24,576 Reduced 26.5%	68,148 $156,000
Q4 2018 Mar 22, 2023	SELL	$2.08 - $3.36 $80,724 - $130,401	-38,810 Reduced 36.29%	68,148 $156,000
Q4 2018 Feb 14, 2019	SELL	$2.08 - $3.36 $80,724 - $130,401	-38,810 Reduced 36.29%	68,148 $157,000
Q3 2018 Jul 13, 2023	SELL	$2.6 - $3.59 $63,897 - $88,227	-24,576 Reduced 26.5%	68,148 $218,000
Q3 2018 Mar 22, 2023	BUY	$2.6 - $3.59 $109,597 - $151,329	42,153 Added 65.05%	106,958 $343,000
Q3 2018 Nov 14, 2018	BUY	$2.6 - $3.59 $14,549 - $20,089	5,596 Added 5.52%	106,958 $343,000
Q2 2018 Aug 15, 2018	BUY	$2.83 - $4.11 $99,310 - $144,228	35,092 Added 52.95%	101,362 $287,000
Q4 2017 Feb 15, 2018	BUY	$3.23 - $4.3 $214,052 - $284,961	66,270	66,270 $257,000

Others Institutions Holding RIGL

# of Institutions

122

Shares Held

110M

Call Options Held

556K

Put Options Held

33.9K

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $1.46B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Rigel Pharmaceuticals Inc Transaction History